212 related articles for article (PubMed ID: 17520777)
21. [Travel at high altitude].
Jean D
Rev Prat; 2015 Apr; 65(4):513-4. PubMed ID: 26058197
[No Abstract] [Full Text] [Related]
22. Methazolamide in high-altitude illnesses.
Lu H; Zhang H; Jiang Y
Eur J Pharm Sci; 2020 May; 148():105326. PubMed ID: 32251722
[TBL] [Abstract][Full Text] [Related]
23. [Mountain sickness].
Zieliński J
Pneumonol Alergol Pol; 1998; 66(11-12):560-7. PubMed ID: 10391965
[No Abstract] [Full Text] [Related]
24. [Etiology, clinical aspects and therapy of altitude sickness].
Berghold F; Schobersberger W
Wien Med Wochenschr; 1994; 144(7):125-9. PubMed ID: 8073777
[TBL] [Abstract][Full Text] [Related]
25. Medical Conditions and High-Altitude Travel.
Luks AM; Hackett PH
N Engl J Med; 2022 Jan; 386(4):364-373. PubMed ID: 35081281
[No Abstract] [Full Text] [Related]
26. Altitude sickness.
Bazian Ltd
Clin Evid; 2004 Jun; (11):1645-50. PubMed ID: 15652074
[No Abstract] [Full Text] [Related]
27. Viagra and health: beyond ED.
Harv Mens Health Watch; 2007 Aug; 12(1):1-4. PubMed ID: 18018319
[No Abstract] [Full Text] [Related]
28. Methazolamide and acetazolamide in acute mountain sickness.
Wright AD; Bradwell AR; Fletcher RF
Aviat Space Environ Med; 1983 Jul; 54(7):619-21. PubMed ID: 6349608
[TBL] [Abstract][Full Text] [Related]
29. [Altitude illness].
Bosch FH
Ned Tijdschr Geneeskd; 1995 Dec; 139(48):2465-7. PubMed ID: 8532078
[No Abstract] [Full Text] [Related]
30. High altitude medicine for family physicians.
McMurray SJ
Can Fam Physician; 1994 Apr; 40():711-8. PubMed ID: 8199523
[TBL] [Abstract][Full Text] [Related]
31. Hypobaric hypoxic cerebral insults: the neurological consequences of going higher.
Maa EH
NeuroRehabilitation; 2010; 26(1):73-84. PubMed ID: 20130356
[TBL] [Abstract][Full Text] [Related]
32. Travelling safely to places at high altitude - Understanding and preventing altitude illness.
Parise I
Aust Fam Physician; 2017 Jun; 46(6):380-384. PubMed ID: 28609593
[TBL] [Abstract][Full Text] [Related]
33. [Ability of patients with coronary heart disease or pulmonary disease for travel at high altitudes].
Fischer R
MMW Fortschr Med; 2009 Mar; 151(11):29-32. PubMed ID: 19469201
[No Abstract] [Full Text] [Related]
34. FPIN's clinical inquiries. Preventing acute mountain sickness.
Kitsteiner JM; Whitworth JD; Nashelsky J
Am Fam Physician; 2011 Aug; 84(4):398-400. PubMed ID: 21842785
[No Abstract] [Full Text] [Related]
35. Current prevention and management of acute mountain sickness.
Bia FJ
Yale J Biol Med; 1992; 65(4):337-41. PubMed ID: 1290275
[TBL] [Abstract][Full Text] [Related]
36. High-altitude illnesses: from the limited to the potentially lethal.
Benner DC
JAAPA; 2007 Jan; 20(1):37-41. PubMed ID: 17252677
[No Abstract] [Full Text] [Related]
37. The role of drugs in high altitude disorders.
Aslam M; Khan MZ
J Pak Med Assoc; 1996 Apr; 46(4):90-2. PubMed ID: 8991363
[No Abstract] [Full Text] [Related]
38. Acute altitude sickness in children.
Neumann K
J Travel Med; 1999 Sep; 6(3):210. PubMed ID: 10576945
[No Abstract] [Full Text] [Related]
39. [Acute Mountain Sickness and High-Altitude Cerebral Edema].
Dehnert C; Bärtsch P
Ther Umsch; 2017; 74(10):535-541. PubMed ID: 29690831
[No Abstract] [Full Text] [Related]
40. Pharmacological prevention of acute mountain sickness. Same ascent rates must be used to assess effectiveness of different doses of acetazolamide.
Bärtsch P; Schneider M
BMJ; 2001 Jan; 322(7277):48-9. PubMed ID: 11141168
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
